PRESCRIPTION DISPENSING & DELIVERY
Iris Health is a specialist pharmacy that dispenses and delivers prescribed Wegovy (semaglutide). Every prescription is verified by a GPhC-registered pharmacist, and refrigerated medication is sent in validated cold-chain packaging.
We fulfil valid private prescriptions with pharmacist-reviewed dispensing, discreet packaging and tracked delivery.
PRESCRIPTION-ONLY MEDICINE
Wegovy (semaglutide) is available only with a valid prescription from a registered healthcare professional following a clinical assessment. Iris Health dispenses against valid prescriptions and does not prescribe.
ABOUT THE MEDICATION
Wegovy is the brand name for semaglutide, a prescription-only injectable weight-management medicine licensed in the UK for eligible adults. It is a GLP-1 receptor agonist administered once weekly using a pre-filled pen.
semaglutide
Mimics a gut hormone involved in appetite, fullness, stomach emptying and blood-glucose regulation.
pre-filled pen
Treatment and dose escalation are managed by the prescribing clinician alongside dietary and lifestyle support.
Made by Novo Nordisk, Wegovy contains the same active ingredient as Ozempic but has a separate UK licence for weight management. Treatment begins at a lower dose and is increased gradually under prescriber guidance so the body can adjust.
HOW IT WORKS
Wegovy activates GLP-1 receptors. This can promote fullness, reduce appetite, slow stomach emptying and influence the brain’s hunger signals.
WHAT IT MAY SUPPORT
Individual responses vary. Treatment decisions, dose changes and monitoring must be managed by the prescribing healthcare professional.
CLINICAL ELIGIBILITY
Wegovy is generally considered for adults with a BMI of 30 kg/m² or above, or 27 kg/m² or above alongside a weight-related condition. Eligibility is always decided by a registered healthcare professional through a full clinical assessment.
The criteria above are a general overview. Only a registered prescriber can determine whether Wegovy is appropriate for an individual.
PRESCRIPTION PROCESS
A registered prescriber must complete the clinical assessment and issue the prescription. Iris Health then verifies, dispenses and delivers it.
Consult a registered prescriber in person or through a properly regulated online service, providing relevant health information.
The prescriber reviews clinical suitability and, if appropriate, issues a prescription at the selected starting dose.
Our pharmacist confirms prescriber authority, patient details, dose and clinical appropriateness before dispensing.
Medication is packed in validated cold-chain packaging and dispatched with tracking and delivery updates.
UK HOME DELIVERY
Iris Health provides refrigerated, tracked Wegovy delivery to eligible UK addresses. Every delivery uses validated cold-chain packaging designed to hold 2–8°C throughout transit.
STORAGE GUIDANCE
Keep Wegovy pens refrigerated at 2–8°C before use and do not freeze them. Once removed, follow the confirmed time and temperature limits below and always check the patient information leaflet enclosed with your pen.
Used pens contain a needle. Dispose of them in an approved sharps container, not household waste. When travelling, carry the pen in hand luggage and use an appropriate medical cool bag.
Storage instructions can be product-specific. If you are unsure whether the medicine has been stored correctly, contact the pharmacy before using it.
SAFETY & MONITORING
Gastrointestinal side effects are commonly reported, particularly when starting treatment or following a dose increase. Serious symptoms require prompt clinical advice.
The patient information leaflet is the authoritative source. Do not stop or change medication without guidance from the prescribing clinical team.
| Side effect | Reported frequency | General guidance |
|---|---|---|
| Nausea | Very common | Often more noticeable early in treatment; discuss concerns with the clinical team. |
| Diarrhoea | Very common | Speak to a pharmacist or prescriber if severe or persistent. |
| Vomiting | Common | Contact the clinical team if severe or affecting hydration. |
| Constipation | Common | Discuss persistent symptoms with the clinical team. |
| Abdominal discomfort | Common | Speak to a pharmacist or prescriber if severe or persistent. |
| Injection-site reactions | Common | Follow administration guidance and discuss ongoing reactions. |
| Persistent severe abdominal pain | Seek advice promptly | Stop and obtain urgent medical advice, as advised in the patient leaflet. |
| Possible gallbladder symptoms | Seek advice promptly | Discuss relevant symptoms with the clinical team promptly. |
Regular clinical reviews are important throughout treatment. Tell your prescriber about new medicines, changes in health or plans for pregnancy.
TREATMENT COMPARISON
Wegovy and Mounjaro are weekly injectable prescription weight-management medicines licensed in the UK. Wegovy acts on GLP-1 receptors; Mounjaro acts on both GLP-1 and GIP receptors. Neither is universally better.
| Feature | Wegovy | Mounjaro |
|---|---|---|
| Active ingredient | Semaglutide | Tirzepatide |
| Mechanism | GLP-1 receptor agonist | Dual GLP-1 and GIP agonist |
| Administration | Weekly subcutaneous injection | Weekly subcutaneous injection |
| UK licensing | Licensed for weight management | Licensed for weight management |
| Prescription | Prescription-only | Prescription-only |
| Refrigeration | 2–8°C required | 2–8°C required |
| Clinical suitability | Prescriber assessment required | Prescriber assessment required |
Iris Health dispenses against valid prescriptions. Your prescriber determines which treatment, if any, is suitable for you.
WHY IRIS HEALTH
A prescription medicine should pass through robust verification, dispensing and delivery checks before reaching the patient.
A GPhC-registered specialist pharmacy with weight-management experience.
Every prescription reviewed before dispensing.
Temperature-controlled packaging selected for the medicine and transit time.
Delivery updates from dispatch to the eligible UK address.
Confidential, tamper-evident outer packaging.
We do not dispense against an invalid or questionable prescription.
OUR COMMITMENT
Every order goes through verification and accuracy checks before it leaves the pharmacy.
GETTING STARTED
If a registered healthcare professional has prescribed Wegovy, Iris Health can verify, dispense and deliver the prescription.
Complete a clinical consultation with a registered prescriber. Iris Health does not prescribe.
Your prescriber can transmit it directly, or the pharmacy team can advise on an appropriate transfer route.
Your medicine is checked, packed with its information leaflet and dispatched using tracked cold-chain delivery.
FREQUENTLY ASKED QUESTIONS
These answers provide general information only. Clinical questions should be directed to the prescribing healthcare professional.
Wegovy is the brand name for semaglutide, a prescription-only once-weekly injectable licensed in the UK for chronic weight management in eligible adults.
It activates GLP-1 receptors, supporting fullness, reducing appetite, slowing stomach emptying and influencing hunger signals alongside dietary change.
Gastrointestinal effects such as nausea, diarrhoea, vomiting and constipation are commonly reported. The patient leaflet is the authoritative source; discuss concerning symptoms with the clinical team.
Tracked cold-chain delivery is available to eligible UK addresses.
Keep pens refrigerated at 2–8°C before use and do not freeze them. Once out of the fridge, store below 30°C for up to 30 days. Follow the supplied patient information leaflet.
Wegovy acts on GLP-1 receptors, while Mounjaro acts on both GLP-1 and GIP receptors. Both require a prescription; treatment choice depends on clinical assessment.
Iris Health is a GPhC-registered pharmacy that dispenses valid private Wegovy prescriptions and provides tracked, temperature-controlled delivery to eligible UK addresses.
